HPC Stock Overview
The Hydration Pharmaceuticals Company Limited markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, the Unites States, and Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
The Hydration Pharmaceuticals Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.02 |
| 52 Week High | AU$0.037 |
| 52 Week Low | AU$0.009 |
| Beta | 1.88 |
| 11 Month Change | 122.22% |
| 3 Month Change | 122.22% |
| 1 Year Change | -45.95% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -94.37% |
Recent News & Updates
Take Care Before Jumping Onto The Hydration Pharmaceuticals Company Limited (ASX:HPC) Even Though It's 31% Cheaper
Jun 25
Sentiment Still Eluding The Hydration Pharmaceuticals Company Limited (ASX:HPC)
May 02Recent updates
Shareholder Returns
| HPC | AU Personal Products | AU Market | |
|---|---|---|---|
| 7D | -13.0% | 2.7% | 0.2% |
| 1Y | -45.9% | 85.1% | 15.9% |
Return vs Industry: HPC underperformed the Australian Personal Products industry which returned 85.1% over the past year.
Return vs Market: HPC underperformed the Australian Market which returned 15.9% over the past year.
Price Volatility
| HPC volatility | |
|---|---|
| HPC Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 13.3% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 3.6% |
Stable Share Price: HPC's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: Insufficient data to determine HPC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Oliver Baker | www.hydralyte.com |
The Hydration Pharmaceuticals Company Limited markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, the Unites States, and Canada. It sells its products under the Hydralyte brand name through retail stores and e-commerce channels. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is headquartered in Melbourne, Australia.
The Hydration Pharmaceuticals Company Limited Fundamentals Summary
| HPC fundamental statistics | |
|---|---|
| Market cap | AU$6.10m |
| Earnings (TTM) | -AU$11.41m |
| Revenue (TTM) | AU$14.41m |
0.4x
P/S Ratio-0.5x
P/E RatioIs HPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HPC income statement (TTM) | |
|---|---|
| Revenue | US$9.70m |
| Cost of Revenue | US$4.27m |
| Gross Profit | US$5.43m |
| Other Expenses | US$13.12m |
| Earnings | -US$7.68m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.025 |
| Gross Margin | 56.00% |
| Net Profit Margin | -79.18% |
| Debt/Equity Ratio | -170.3% |
How did HPC perform over the long term?
See historical performance and comparison